| Name | Tate & Lyle |
|---|---|
| Epic | TATE |
| Isin | GB00BP92CJ43 |
| Index | UK250 UK350 |
| Industry | Food Producers |
| Latest share price | 651.00p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £2,899.75 | Debt ratio | n/a |
| Shares in issue | 449.72 | Debt-to-equity ratio | n/a |
| P/E ratio | 11.1 | Assets / equity ratio | n/a |
| Total dividends per share | 6.40p | Price to book value | n/a |
| Dividend yield | 3.1 | ROCE | 16.07 |
| Dividend cover | 2.91 | EPS growth | 12 |
| Earning per share | 45.2 | 52-week high / low | 591.00p / 807.00p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| Interim | 2024-11-21 | 2025-01-06 | 6.40p |
| Final | 2024-06-20 | 2024-08-02 | 12.90p |
| Interim | 2023-11-23 | 2024-01-05 | 6.20p |
| Final | 2023-06-22 | 2023-08-02 | 13.10p |
| Interim | 2022-11-24 | 2023-01-04 | 5.40p |
| Final | 2022-06-30 | 2022-08-05 | 12.80p |
| Special | 2022-05-03 | 2022-05-16 | 107.00p |
| Interim | 2021-11-25 | 2022-01-05 | 9.00p |
| Final | 2021-06-24 | 2021-08-06 | 22.00p |
| Company name | Tate & Lyle |
|---|---|
| Address | 5 Marble Arch, London, United Kingdom, W1H 7EJ |
| Telephone | +44 (0) 20 72572100 |
| Website | http://www.tateandlyle.com |
| Director | Position |
|---|---|
| Mr Nick Hampton | CEO |
| Ms Sarah Kuijlaars | CFO |
| Mr David Hearn | Chairman |
| Mr Jeffrey Carr | Non-Executive Director |
| Ms Kimberly Nelson | Senior Independent Director |
| Ms Patrícia Corsi | Independent Non-Executive Director |
| Ms Sybella Stanley | Independent Non-Executive Director |
| Mr John Cheung | Independent Non-Executive Director |
| Dr Isabelle Esser | Independent Non-Executive Director |
| Mr Lars Frederiksen | Independent Non-Executive Director |
| Mr Warren Tucker | Independent Non-Executive Director |
| Assets £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Reporting date | 31/03/24 | 31/03/23 | 31/03/22 |
| Intangible asssets and goodwill | 406 | 452 | 278 |
| Investments and other non-current assets | 193 | 241 | 46 |
| Total non-current assets | 1195 | 1223 | 791 |
| Inventory / work in progress | 353 | 446 | 317 |
| Trade and other receivables | 294 | 351 | 270 |
| Cash and equivalents | 437 | 475 | 110 |
| Other current assets and asset held for resale | 3 | 12 | 26 |
| Total of all assets | 2282 | 2507 | 3251 |
| Liabilities £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Short term liabilities | 338 | 572 | 380 |
| Long term liabilities | 705 | 745 | 851 |
| Other liabilites / pension etc | n/a | n/a | 400 |
| Total of all liabilities | 1043 | 1317 | 1631 |
| Net assets £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net assets | 1239 | 1190 | 1620 |
| Equity £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Share capital | 117 | 117 | 117 |
| Minority interests | 1 | 1 | 1 |
| Retained earnings | 623 | 513 | 865 |
| Share premium account | 408 | 408 | 407 |
| Total equity | 1239 | 1190 | 1620 |
| Income £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | 207 | 196 | 67 |
| Pre-tax profit | 226 | 152 | 42 |